ArticleFrontiers in pharmacology2022
World Health Organization (WHO) International Classification of Functioning, Disability and Health (ICF) Core Set Development for Interstitial Lung Disease.
Open access · goldAbstract read
In one paragraph
Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 6% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.
- Utilisation of cardiopulmonary exercise testing for tailored pulmonary rehabilitation in people with interstitial lung diseases: A systematic review.Clinical rehabilitation · 2026Pooled it
- An online, two-day educational seminar had no impact on disease-specific knowledge in patients with systemic sclerosis.Scientific reports · 2024Trial
- Article
- Establishing the content validity of patient-reported outcome measures used in neuro-oncology based on the WHO ICF framework: Part of the RANO-PRO initiative.Neuro-oncology · 2025Article
- Home Monitoring in Interstitial Lung Disease: Protocol for a Real-World Observational Study.JMIR research protocols · 2025Article
- Vitamin D and Colorectal Cancer Prevention: Immunological Mechanisms, Inflammatory Pathways, and Nutritional Implications.Nutrients · 2025Review
- Tuberculosis-associated respiratory impairment and disability in children and adolescents: a systematic review.EClinicalMedicine · 2025Article
- Comparative Pharmacokinetics Research of 13 Bioactive Components of Jieyu Pills in Control and Attention Deficit Hyperactivity Disorder Model Rats Based on UPLC-Orbitrap Fusion MS.Molecules (Basel, Switzerland) · 2024Article
- Exploring the potential of cardiopulmonary exercise testing (CPET) for tailored pulmonary rehabilitation in people with interstitial lung disease (ILD): A systematic review protocol.NIHR open research · 2024Article
- Changes in patient-reported outcomes in patients with non-idiopathic pulmonary fibrosis fibrotic interstitial lung disease and progressive pulmonary fibrosis.Frontiers in medicine · 2023Article
- Editorial: Pulmonary fibrosis: One manifestation, various diseases.Frontiers in pharmacology · 2022Article
- Patient-reported quality of life (QoL) measurements in adults with multiple long-term conditions: A scoping review protocol.Journal of multimorbidity and comorbidityArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
29 authors at 20 institutions in 8 countries.
Lesley Ann SaketkooNew Orleans Scleroderma and Sarcoidosis Patient Care and Research Center, New Orleans, LA, United States.
Reuben EscorpizoDepartment of Rehabilitation and Movement Science, The University of Vermont, Burlington, VT, United States.
Janos VargaDepartment of Pulmonology, Semmelweis University, Budapest, Hungary.
Kevin John KeenDepartment of Mathematics and Statistics and Health Research Institute, University of Northern British Columbia, Prince George, BC, Canada.
Kim FligelstonePatient Research Partner Scleroderma & Raynaud Society, UK (SRUK) and Federation of European Scleroderma Associations, London, United Kingdom.
Surinder S BirringDivision of Asthma, Allergy and Lung Biology, King's College London, London, United Kingdom.
Helene AlexandersonWomen's Health and Allied Health Professionals, Medical Unit Occupational Therapy and Physiotherapy, Karolinska University Hospital, Stockholm, Sweden.
Henrik PetterssonWomen's Health and Allied Health Professionals, Medical Unit Occupational Therapy and Physiotherapy, Karolinska University Hospital, Stockholm, Sweden.
Humza Ahmad ChaudhryNew Orleans Scleroderma and Sarcoidosis Patient Care and Research Center, New Orleans, LA, United States.
Janet L PooleOccupational Therapy Graduate Program, University of New Mexico, Albuquerque, NM, United States.
Malin RegardtWomen's Health and Allied Health Professionals, Medical Unit Occupational Therapy and Physiotherapy, Karolinska University Hospital, Stockholm, Sweden.
Daphne LeSagePatient Research Partner, New Orleans, LA, United States.
Catherine SarverPatient Research Partner, Baltimore, MD, United States.
Joseph LanarioResearch Fellow in Respiratory Health-Exeter Respiratory Institute Royal Devon University Hospitals NHS Foundation Trust, Exeter, United Kingdom.
Elisabetta RenzoniRoyal Brompton Hospital, National Heart and Lung Institute, London, United Kingdom.
Mary Beth ScholandPulmonary Medicine, University of Utah, Salt Lake City, UT, United States.
Matthew R LammiNew Orleans Scleroderma and Sarcoidosis Patient Care and Research Center, New Orleans, LA, United States.
Otylia Kowal-BieleckaUniversity of Bialystok, Bialystok, Poland.
Oliver DistlerDivision of Rheumatology, University Hospital Zurich, Zurich, Switzerland.
Tracy FrechDivision of Rheumatology Vanderbilt University School of Medicine, Nashville, TN, United States.
Lee ShapiroDivision of Rheumatology, Albany Medical Center, Albany, NY, United States.
Cecilia VarjuDepartment of Rheumatology and Immunology, Medical School, University of Pécs, Pecs, Hungary.
Elizabeth R VolkmannDepartment of Medicine, David Geffen School of Medicine, UCLA Scleroderma Program and UCLA CTD-ILD Program, Division of Rheumatology, University of California, Los Angeles, Los Angeles, CA, United States.
Elana J BernsteinDepartment of Medicine, Columbia University/New York-Presbyterian Scleroderma Program, Division of Rheumatology, Columbia University College of Physician2s and Surgeons, New York, NY, United States.
Marjolein DrentDepartment of Pulmonology, Interstitial Lung Diseases (ILD) Center of Excellence, St. Antonius Hospital, Nieuwegein, Netherlands.
Ogugua Ndili ObiDepartment of Internal Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, Brody School of Medicine, East Carolina University, Greenville, NC, United States.
Karen C PattersonDepartment of Clinical & Experimental Medicine, Brighton & Sussex Medical School, Falmer, United Kingdom.
Anne-Marie RussellRespiratory Institute to Exeter Respiratory Innovation Center, University of Exeter, Exeter, United Kingdom.
Global Fellowship on Rehabilitation and Exercise in Systemic Sclerosis (G-FoRSS)
Karolinska Institutet · SETulane University · USColumbia University · USEast Carolina University · USKarolinska University Hospital · SEKing's College London · GBMaastricht University · NLRoyal Brompton Hospital · GBScleroderma Foundation · USSemmelweis University · HUUniversity College London · GBUniversity Hospital and Clinics · USUniversity Hospital of Zurich · CHUniversity of Białystok · PLUniversity of British Columbia · CAUniversity of California, Los Angeles · USUniversity of Exeter · GBUniversity of New Mexico · USUniversity of Pecs · HUUniversity of Pennsylvania · US
Funding
Versus Arthritis 20719
Abstract
PubMed holds no abstract for this paper.
Indexed as
connective tissuecoughCTD-ILDfibrosisICD-11patient-reported outcomes
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.